Rheumatology Advance Access published online on August 22, 2007
Rheumatology, doi:10.1093/rheumatology/kem203
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Cytokines in arthritis—the big numbers move centre stage
Division of Rheumatology, Department of Medicine, University of Cambridge.
Correspondence to:
Department of Medicine, Box 157, Level 5, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK. E-mail: jshg2{at}medschl.cam.ac.uk
| Abstract |
|---|
More than 20 yrs ago, T-helper lymphocytes were divided into Th1 and Th2 subsets on the basis of their cytokine production. The pro-inflammatory Th1 subset was considered predominant in inflammatory arthritis, but evidence for this notion was incomplete, and some called into question the role of helper T cells. The identification of a novel T cell subset, Th17 cells, which appears to be critical for several forms of autoimmune inflammation, including arthritis, requires a reconsideration of arthritis pathogenesis and the role of T cells. This review deals with several of the newly described (big number) cytokines which are involved in the differentiation and action of Th17 cells, and pays particular attention to the pathogenesis of spondyloarthritis because of the implication of the same cytokine networks in psoriasis and inflammatory bowel disease. The role of dendritic cells as coordinators of T cell differentiation in response to pathogen-derived signals in also emphasized.
KEY WORDS: cytokines, spondyloarthritis, Th17, dendritic cells
Submitted 10 April 2007;
revised version accepted 3 July 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?